Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-10-14Clinical Trial Update: Lot-to-lot Consistency of Sci-B-Vac™ in Adults [Phase 3]
Phase 3 trial updating lot-to-lot consistency of Sci-B-Vac in adults completed with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-10-08Clinical Trial Update: A Comparative Trial of Improving Care for Underserved Asian Americans Infected With HBV [NA]
Completed clinical trial evaluating care improvements for underserved Asian Americans with Hepatitis B; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-10-01Clinical Trial Update: Hepatitis B Vaccination in Infants [Phase 4]
A Phase 4 clinical trial update on Hepatitis B vaccination in infants has completed, with sponsor Public Health England evaluating vaccinati…
-
CLINICAL_TRIALS trial_result · 2020-09-30Clinical Trial Update: Study on Antiviral Therapy for HBeAg-positive Chronic Hepatitis B Patients Aged 1-16 Years [Phase 4]
A Phase 4 clinical trial update on antiviral therapy for HBeAg-positive chronic hepatitis B in pediatric patients aged 1-16 years. Status an…
-
CLINICAL_TRIALS trial_result · 2020-09-10Clinical Trial Update: Pradefovir Treatment for the Patients With Chronic Hepatitis B Virus Infections: a Phase3 Study [Phase 3]
Phase 3 trial update for pradefovir in chronic hepatitis B patients; status not reported.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-09-09Clinical Trial Update: Immunogenicity of the Hepatitis B Vaccine [Phase 4]
Phase 4 trial update on the immunogenicity of a Hepatitis B vaccine evaluating vaccine response in impaired populations, including aging-rel…
-
CLINICAL_TRIALS trial_result · 2020-09-02Clinical Trial Update: Study To Evaluate Safety and Efficacy of Vesatolimod for the Treatment of Chronic Hepatitis B Virus in Virally-Suppressed Participants [Phase 2]
Phase 2 trial evaluating safety and efficacy of vesatolimod for chronic hepatitis B in virally-suppressed participants has completed with re…
-
CLINICAL_TRIALS trial_result · 2020-08-24Clinical Trial Update: A Study of Pegylated Interferon Alfa-2A in Combination With Lamivudine or Entecavir Compared With Untreated Control Group in Children With Hepatitis B Envelope Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) in the Immune-Tolerant Phase [Phase 3]
Phase 3 trial of pegylated interferon alfa-2a with lamivudine or entecavir versus untreated control in children with immune-tolerant, HBeAg-…
-
FDA approval · 2020-08-18FDA Approved: VEMLIDY — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for Vemlidy (tenofovir alafenamide) submitted by Gilead Sciences. The approval updates the produ…
-
CLINICAL_TRIALS trial_result · 2020-07-31Clinical Trial Update: HBV Vaccine in Anti-core Positive Donors After LT [Phase 2]
Phase 2 clinical trial update on an HBV vaccine in anti-core positive donors after liver transplant (HBV reactivation condition).
-
CLINICAL_TRIALS trial_result · 2020-07-23Clinical Trial Update: The Safety, Antiviral Activity, and Pharmacokinetics of Morphothiadine Mesilate Capsules [Phase 2]
Phase 2 trial update reports on safety, antiviral activity, and pharmacokinetics of Morphothiadine Mesilate capsules for chronic hepatitis B…
-
CLINICAL_TRIALS trial_result · 2020-07-15Clinical Trial Update: Safety Study of a Tenofovir-containing Drug Regimen for the Prevention of Mother-to-child Transmission of HIV and HBV [Phase 2]
Phase 2 safety study evaluating a tenofovir-containing regimen for preventing mother-to-child transmission of HIV and hepatitis B has comple…
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: Immunogenicity and Safety of Sci-B-Vac® to Engerix-B® in Adults [Phase 3]
A Phase 3 trial comparing immunogenicity and safety of Sci-B-Vac® to Engerix-B® in adults with completed status and results posted.
-
CLINICAL_TRIALS trial_result · 2020-06-25Clinical Trial Update: Entecavir to TAF Switch [Phase 3]
Clinical trial update on switching from entecavir to tenofovir alafenamide (TAF) in Hepatitis B patients (Phase 3, active not recruiting).
-
FDA approval · 2020-06-18FDA Approved: ENTECAVIR — Supplemental Application (NorthStar RxLLC)
The FDA approved NorthStar RxLLC's supplemental application for Entecavir (generic entecavir) under ANDA 206872.
-
FDA approval · 2020-06-18FDA Approved: ENTECAVIR — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for ENTECAVIR from Aurobindo Pharma Limited under the ANDA, enabling continued marketing of the gene…
-
FDA approval · 2020-06-18FDA Approved: ENTECAVIR — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application to allow Zydus Lifesciences Limited to market a generic entecavir (ENTECAVIR) in the United States.
-
FDA approval · 2020-06-16FDA Approved: ENTECAVIR — Supplemental Application (AvKARE)
FDA approves a supplemental application for AvKARE to market entecavir, expanding the generic supply of the antiviral for chronic hepatitis …
-
CLINICAL_TRIALS withdrawal · 2020-06-01Clinical Trial Update: Combination Hepatitis A and B Vaccine to Induce Immunity in Non-responders [Phase 4]
A Phase 4 trial evaluating a combination Hepatitis A and B vaccine in non-responders has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2020-05-18Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Efficacy of Vesatolimod in Combination With Tenofovir Disoproxil Fumarate (TDF) in Adults With Chronic Hepatitis B (CHB) Infection Who Are Currently Not Being Treated [Phase 2]
Phase 2 study evaluating vesatolimod in combination with TDF for adults with chronic hepatitis B completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-04-09Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) From Tenofovir Disoproxil Fumarate (TDF) and/or Other Oral Antiviral Treatment (OAV) [Phase 2]
Phase 2 study evaluating switching to tenofovir alafenamide (TAF) from tenofovir disoproxil fumarate (TDF) and/or other oral antiviral treat…
-
CLINICAL_TRIALS trial_result · 2020-04-01Clinical Trial Update: Safety, Tolerability and Antiviral Activity of Selgantolimod in Virally-Suppressed Participants With Chronic Hepatitis B [Phase 2]
Phase 2 trial evaluating safety, tolerability, and antiviral activity of selgantolimod in virally-suppressed adults with chronic hepatitis B…
-
CLINICAL_TRIALS trial_result · 2020-03-31Clinical Trial Update: Hepatitis B en Haitian Immigrants in Chile: Molecular Characterization and Determination of Vaccine Response [Phase 4]
Phase 4 trial update on Hepatitis B in Haitian immigrants in Chile focusing on molecular characterization and vaccine response.
-
CLINICAL_TRIALS trial_result · 2020-03-04Clinical Trial Update: TAF for HIV-HBV With Renal Dysfunction [Phase 2]
Phase 2 clinical trial update evaluating tenofovir alafenamide (TAF) for HIV and Hepatitis B coinfection in patients with renal dysfunction …
-
CLINICAL_TRIALS trial_result · 2020-03-03Clinical Trial Update: A Trial To Study The Effect Of Lamivudine In Adult Patients Who Suffer From Chronic Hepatitis B Alone [Phase 4]
Phase 4 clinical trial evaluating the effect of lamivudine in adults with chronic hepatitis B; study completed.